Bank of Montreal’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,849
Closed -$75.4K 4201
2024
Q2
$75.4K Buy
+12,849
New +$115K ﹤0.01% 3327
2024
Q1
Sell
-131,500
Closed -$901K 4281
2023
Q4
$901K Buy
+131,500
New +$420K ﹤0.01% 2113
2021
Q2
Sell
-49
Closed -$4K 4773
2021
Q1
$4K Sell
49
-1,580
-97% -$175K ﹤0.01% 4757
2020
Q4
$154K Buy
1,629
+1,553
+2,043% +$98.2K ﹤0.01% 3361
2020
Q3
$5K Sell
76
-55
-42% -$2.11K ﹤0.01% 4449
2020
Q2
$6K Buy
+131
New +$5.44K ﹤0.01% 4385
2020
Q1
Sell
-173
Closed -$12K 4637
2019
Q4
$12K Buy
173
+58
+50% +$6.4K ﹤0.01% 4524
2019
Q3
$18K Buy
115
+29
+34% +$3.28K ﹤0.01% 4159
2019
Q2
$7K Buy
+86
New +$9.38K ﹤0.01% 4625
2019
Q1
Sell
-11
Closed -$2.76K 4700
2018
Q4
$5K Buy
11
+5
+83% +$2.35K ﹤0.01% 4102
2018
Q3
$4K Buy
6
+2
+50% +$1.26K ﹤0.01% 4179
2018
Q2
$2K Buy
+4
New +$1.23K ﹤0.01% 4396

Other funds holding SLDB

Bank of Montreal's SLDB Position: Q3 2024 in Review

Bank of Montreal sold out of Solid Biosciences (SLDB) in Q3 2024, closing a stake of 12,849 shares — an estimated $75.4K sold.

Bank of Montreal first reported a position in SLDB in Q2 2018 and held it in 12 quarters. The position peaked at $901K in Q4 2023. 92 funds tracked by Wall St. Rank hold SLDB as of Q3 2024.

  • Bank of Montreal reported no remaining Solid Biosciences position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 12,849 Solid Biosciences shares in Q3 2024, an estimated $75.4K.
  • Bank of Montreal first reported a position in Solid Biosciences in Q2 2018 and held it in 12 quarters.
  • Bank of Montreal's Solid Biosciences position peaked at $901K in Q4 2023.
  • 92 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.